Published in
Oxford University Press, Japanese Journal of Clinical Oncology, p. hyv193
DOI: 10.1093/jjco/hyv193
Links
Tools
A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer
Journal article published in 2016 by
Hiroya Taniguchi,
Azusa Komori,
Yukiya Narita,
Shigenori Kadowaki,
Takashi Ura,
Masashi Andoh,
Yasushi Yatabe 
,
Koji Komori,
Kenichi Kimura,
Takashi Kinoshita,
Kei Muro
,
Koji Komori,
Kenichi Kimura,
Takashi Kinoshita,
Kei Muro
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 